Pediatric interventional cardiology

2009

Matthew A. Crystal, Frank Ing

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Purpose of Review: Pediatric interventional cardiology has evolved quite dramatically over the past few decades and now, in 2009, the published literature continues to evolve new percutaneous strategies for managing patients with congenital heart disease, both simple and complex. Our goal for this review was to highlight new techniques and the new devices available to the pediatric interventional cardiologist, and to review the outcomes from past endeavors. Recent Finddings: Manuscripts published in the past year continue to demonstrate innovation; indicating an exciting and increasing experience of transcatheter treatment of septal communications using either new occluder devices or novel techniques. Bioabsorbable devices and percutaneously implanted valves are leading examples of technological improvements and creativity that will ultimately improve patient outcomes while minimizing invasiveness. Reports on procedural outcomes show technically safe early follow-up, with promising mid-term and long-term results for balloon valvuloplasty, balloon atrial septostomy and pulmonary artery stent implantation. As well, fetal and hybrid interventions have become important new arenas for the pediatric interventionist. Summary: Pediatric interventions have grown far beyond the early stages of the 1980s as mid-term and long-term outcome data are being reported, and many previously insurmountable hurdles have been overcome by developing new strategies and devices.

Original languageEnglish (US)
Pages (from-to)567-572
Number of pages6
JournalCurrent Opinion in Pediatrics
Volume22
Issue number5
DOIs
StatePublished - Oct 1 2010
Externally publishedYes

Fingerprint

Cardiology
Pediatrics
Equipment and Supplies
Balloon Valvuloplasty
Creativity
Manuscripts
Pulmonary Artery
Stents
Heart Diseases
Communication
Therapeutics

Keywords

  • cardiac catheterization
  • congenital heart disease
  • device occluder
  • fetus
  • intervention
  • stent
  • ybrid procedure

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Pediatric interventional cardiology : 2009. / Crystal, Matthew A.; Ing, Frank.

In: Current Opinion in Pediatrics, Vol. 22, No. 5, 01.10.2010, p. 567-572.

Research output: Contribution to journalReview article

Crystal, Matthew A. ; Ing, Frank. / Pediatric interventional cardiology : 2009. In: Current Opinion in Pediatrics. 2010 ; Vol. 22, No. 5. pp. 567-572.
@article{394a370f1dc04b06baf8eccd05de3ab4,
title = "Pediatric interventional cardiology: 2009",
abstract = "Purpose of Review: Pediatric interventional cardiology has evolved quite dramatically over the past few decades and now, in 2009, the published literature continues to evolve new percutaneous strategies for managing patients with congenital heart disease, both simple and complex. Our goal for this review was to highlight new techniques and the new devices available to the pediatric interventional cardiologist, and to review the outcomes from past endeavors. Recent Finddings: Manuscripts published in the past year continue to demonstrate innovation; indicating an exciting and increasing experience of transcatheter treatment of septal communications using either new occluder devices or novel techniques. Bioabsorbable devices and percutaneously implanted valves are leading examples of technological improvements and creativity that will ultimately improve patient outcomes while minimizing invasiveness. Reports on procedural outcomes show technically safe early follow-up, with promising mid-term and long-term results for balloon valvuloplasty, balloon atrial septostomy and pulmonary artery stent implantation. As well, fetal and hybrid interventions have become important new arenas for the pediatric interventionist. Summary: Pediatric interventions have grown far beyond the early stages of the 1980s as mid-term and long-term outcome data are being reported, and many previously insurmountable hurdles have been overcome by developing new strategies and devices.",
keywords = "cardiac catheterization, congenital heart disease, device occluder, fetus, intervention, stent, ybrid procedure",
author = "Crystal, {Matthew A.} and Frank Ing",
year = "2010",
month = "10",
day = "1",
doi = "10.1097/MOP.0b013e32833e1328",
language = "English (US)",
volume = "22",
pages = "567--572",
journal = "Current Opinion in Pediatrics",
issn = "1040-8703",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Pediatric interventional cardiology

T2 - 2009

AU - Crystal, Matthew A.

AU - Ing, Frank

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Purpose of Review: Pediatric interventional cardiology has evolved quite dramatically over the past few decades and now, in 2009, the published literature continues to evolve new percutaneous strategies for managing patients with congenital heart disease, both simple and complex. Our goal for this review was to highlight new techniques and the new devices available to the pediatric interventional cardiologist, and to review the outcomes from past endeavors. Recent Finddings: Manuscripts published in the past year continue to demonstrate innovation; indicating an exciting and increasing experience of transcatheter treatment of septal communications using either new occluder devices or novel techniques. Bioabsorbable devices and percutaneously implanted valves are leading examples of technological improvements and creativity that will ultimately improve patient outcomes while minimizing invasiveness. Reports on procedural outcomes show technically safe early follow-up, with promising mid-term and long-term results for balloon valvuloplasty, balloon atrial septostomy and pulmonary artery stent implantation. As well, fetal and hybrid interventions have become important new arenas for the pediatric interventionist. Summary: Pediatric interventions have grown far beyond the early stages of the 1980s as mid-term and long-term outcome data are being reported, and many previously insurmountable hurdles have been overcome by developing new strategies and devices.

AB - Purpose of Review: Pediatric interventional cardiology has evolved quite dramatically over the past few decades and now, in 2009, the published literature continues to evolve new percutaneous strategies for managing patients with congenital heart disease, both simple and complex. Our goal for this review was to highlight new techniques and the new devices available to the pediatric interventional cardiologist, and to review the outcomes from past endeavors. Recent Finddings: Manuscripts published in the past year continue to demonstrate innovation; indicating an exciting and increasing experience of transcatheter treatment of septal communications using either new occluder devices or novel techniques. Bioabsorbable devices and percutaneously implanted valves are leading examples of technological improvements and creativity that will ultimately improve patient outcomes while minimizing invasiveness. Reports on procedural outcomes show technically safe early follow-up, with promising mid-term and long-term results for balloon valvuloplasty, balloon atrial septostomy and pulmonary artery stent implantation. As well, fetal and hybrid interventions have become important new arenas for the pediatric interventionist. Summary: Pediatric interventions have grown far beyond the early stages of the 1980s as mid-term and long-term outcome data are being reported, and many previously insurmountable hurdles have been overcome by developing new strategies and devices.

KW - cardiac catheterization

KW - congenital heart disease

KW - device occluder

KW - fetus

KW - intervention

KW - stent

KW - ybrid procedure

UR - http://www.scopus.com/inward/record.url?scp=77957584766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957584766&partnerID=8YFLogxK

U2 - 10.1097/MOP.0b013e32833e1328

DO - 10.1097/MOP.0b013e32833e1328

M3 - Review article

VL - 22

SP - 567

EP - 572

JO - Current Opinion in Pediatrics

JF - Current Opinion in Pediatrics

SN - 1040-8703

IS - 5

ER -